2751 - 2760 of 6560 Results
Title
Year
- Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide2020OPENTitle: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and SafinamideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 343End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12921Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134126Citation Count: 338
-
OPENTitle: Disruption of Mitochondrial Complex I Induces Progressive ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 478End Page: 478Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28961Best OA location URL: https://doi.org/10.1002/mds.28961Citation Count: 15
-
OPENTitle: 32nd International Symposium on the Autonomic Nervous SystemJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 5Start Page: 591End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-021-00822-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-021-00822-5.pdfCitation Count: 2
-
OPENTitle: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 648417End Page: 648417Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648417/pdfCitation Count: 11
-
OPENTitle: Characterizing enteric neurons in dopamine transporter (DAT)‐Cre reporter mice reveals dopaminergic subtypes with dual‐transmitter contentJournal Name: European Journal of NeurosciencePublisher: WileyVol: 59Issue #: 10Start Page: 2465End Page: 2482Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16307Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16307Citation Count: 2
-
OPENTitle: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 7Start Page: e2223821End Page: e2223821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdfCitation Count: 13
-
OPENTitle: Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard ScoreJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 62End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28808Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28808Citation Count: 20
-
OPENTitle: Item Response Theory Analysis of the MDS‐UPDRS Motor Examination: Tremor vs. Nontremor ItemsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1587End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28110Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28110Citation Count: 31
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 42
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 61